Publications
3 shownDissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
A detailed understanding of the mechanisms by which tumors acquire resistance to targeted anticancer agents should speed the development of treatment strategies with lasting cli...
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Oncogenic mutations in the serine/threonine kinase B-RAF (also known as BRAF) are found in 50–70% of malignant melanomas. Pre-clinical studies have demonstrated that the B-RAF(V...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 3,416
- Institution
- Dana-Farber Cancer Institute
External Links
Identifiers
- ORCID
- 0000-0001-7373-3916
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.